The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 27,532,830 | 2,404,614 | SH | OTR | 1 | 0 | 2,404,614 | 0 | |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 3,175,848 | 1,363,025 | SH | OTR | 1 | 0 | 1,363,025 | 0 | |
BIONOMICS LIMITED | ADS | 09063M205 | 2,201,882 | 815,512 | SH | OTR | 1 | 0 | 815,512 | 0 | |
C4 THERAPEUTICS INC | COM STK | 12529R107 | 1,895,768 | 1,019,230 | SH | OTR | 1 | 0 | 1,019,230 | 0 | |
CABALETTA BIO INC | COM | 12674W109 | 32,053,320 | 2,106,000 | SH | OTR | 1 | 0 | 2,106,000 | 0 | |
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 14,822,941 | 994,161 | SH | OTR | 1 | 0 | 994,161 | 0 | |
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 24,840 | 18,265 | SH | OTR | 1 | 0 | 18,265 | 0 | |
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 11,086,939 | 1,103,178 | SH | OTR | 1 | 0 | 1,103,178 | 0 | |
KINNATE BIOPHARMA INC | COM | 49705R105 | 2,795,808 | 1,997,006 | SH | OTR | 1 | 0 | 1,997,006 | 0 | |
MERUS N V | COM | N5749R100 | 27,122,306 | 1,150,225 | SH | OTR | 1 | 0 | 1,150,225 | 0 | |
NEKTAR THERAPEUTICS | COM | 640268108 | 1,052,315 | 1,766,815 | SH | OTR | 1 | 0 | 1,766,815 | 0 | |
PASSAGE BIO INC | COM | 702712100 | 125,102 | 190,124 | SH | OTR | 1 | 0 | 190,124 | 0 | |
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 2,913,203 | 9,775,849 | SH | OTR | 1 | 0 | 9,775,849 | 0 | |
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 2,315,428 | 235,787 | SH | OTR | 1 | 0 | 235,787 | 0 | |
STOKE THERAPEUTICS INC | COM | 86150R107 | 6,738,007 | 1,710,154 | SH | OTR | 1 | 0 | 1,710,154 | 0 | |
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 1,889,496 | 702,415 | SH | OTR | 1 | 0 | 702,415 | 0 | |
TSCAN THERAPEUTICS INC | COM | 89854M101 | 13,374,976 | 5,224,600 | SH | OTR | 1 | 0 | 5,224,600 | 0 | |
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 65,452 | 9,917 | SH | OTR | 1 | 0 | 9,917 | 0 |